After adjusting for confounders, including patient demographics, tumor-specific variables, and laboratory values, the strong relationship between GDF-15 and all-cause mortality persisted (adjusted HR: 1.37; 95% CI: 1.25-1.50) (Figure 5). Here, GDF15 is linked to neoplasm.